Department of Medical Research, SRM Medical College Hospital and Research Centre, SRM University, Kattankulathur, Tamilnadu, India.
Department of Microbiology, Shri Sathya Sai Medical College and Research Institute, Thiruporur, Tamilnadu, India.
Biomed Pharmacother. 2017 Sep;93:81-87. doi: 10.1016/j.biopha.2017.06.035. Epub 2017 Jun 16.
The increasing rate of obesity in the past years has become a worldwide concern and it causes many diseases. Even though, Orlistat, a synthetic anti-obesity drug approved by FDA, it causes severe side effects. DATS, a natural product from garlic have gained attention in many biological activities. The aim of the study is to determine the impact of Dially trisulpide (DATS) and its combination with Orlistat therapy on obese animals. 30 male Wistar rats (150-180g) were assigned into 5 groups (n=6). Group 1 rats received normal diet and Group 2 fed with high fat diet (HFD) for 14 weeks. Group 3-5 animals fed with HFD for 8 weeks, after that respective drugs were given simultaneously along with HFD for 6 weeks; Group 3: HFD+Orlistat; Group 4: HFD+DATS; Group 5: HFD+Orlistat+DATS. Before and after drug treatment, body weight was measured and blood was collected for assessment of lipid and liver function profiles. After end of the treatment 14 weeks, liver and adipose tissues were collected for antioxidants determination and histological observations. The significantly (p<0.05) increased body weight, serum glucose, total cholesterol, triglycerides, LDL-cholesterol were observed while significantly (p<0.05) decreased HDL-cholesterol and liver function parameters in HFD induced rats when compared to control group. The significantly (p<0.05) decreased activities of SOD, CAT, GPx and GSH levels were observed while significantly (p<0.05) increased LPO in both the tissues of HFD treated group when compared to control. Histopathological changes were observed in both the liver and adipose tissue of HFD treated group. The DATS and its combination with orlistat supplementation restored all the parameters significantly (p<0.05) especially liver function parameters and also retrieved histopathological changes when compared to orlistat alone. DATS and its combination with Orlistat had great effect than Orlistat alone.
过去几年肥胖率的不断上升已成为全球关注的问题,它会导致许多疾病。尽管 FDA 批准了奥利司他(一种合成的抗肥胖药物),但它会引起严重的副作用。大蒜中的天然产物 DATS 在许多生物活性方面引起了关注。本研究的目的是确定 Diallyl trisulfide(DATS)及其与奥利司他治疗联合对肥胖动物的影响。将 30 只雄性 Wistar 大鼠(150-180g)分为 5 组(n=6)。第 1 组大鼠给予正常饮食,第 2 组给予高脂肪饮食(HFD)14 周。第 3-5 组动物给予 HFD 8 周,然后同时给予相应的药物,并与 HFD 一起给予 6 周;第 3 组:HFD+奥利司他;第 4 组:HFD+DATS;第 5 组:HFD+奥利司他+DATS。在药物治疗前后测量体重,并采集血液评估血脂和肝功能谱。治疗结束后 14 周,收集肝脏和脂肪组织进行抗氧化剂测定和组织学观察。与对照组相比,HFD 诱导的大鼠体重、血清葡萄糖、总胆固醇、甘油三酯、LDL-胆固醇显著升高(p<0.05),而 HDL-胆固醇和肝功能参数显著降低(p<0.05)。与对照组相比,HFD 治疗组的两种组织中 SOD、CAT、GPx 和 GSH 水平的活性显著降低(p<0.05),而 LPO 水平显著升高(p<0.05)。HFD 治疗组的肝脏和脂肪组织均观察到组织病理学变化。与单独使用奥利司他相比,DATS 及其与奥利司他联合补充显著恢复了所有参数(p<0.05),特别是肝功能参数,并恢复了组织病理学变化。DATS 及其与奥利司他的联合作用优于单独使用奥利司他。